董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| James W. Bracke | 男 | Director | 76 | 1.82万美元 | 未持股 | 2023-06-20 |
| Terrence W. Glarner | 男 | Chairman of the Board,Director | 80 | 1.92万美元 | 未持股 | 2023-06-20 |
| Daniel A. Baker | 男 | President and CEO,Director | 65 | 105.55万美元 | 未持股 | 2023-06-20 |
| Patricia M. Hollister | 女 | Director | 63 | 1.87万美元 | 未持股 | 2023-06-20 |
| Richard W. Kramp | 男 | Director | 77 | 1.82万美元 | 未持股 | 2023-06-20 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Peter G. Eames | 男 | Vice President, Advanced Technology | 47 | 26.97万美元 | 未持股 | 2023-06-20 |
| Daniel Nelson | 男 | Accounting Manager and Principal Financial Officer | 37 | 3.63万美元 | 未持股 | 2023-06-20 |
| Daniel A. Baker | 男 | President and CEO,Director | 65 | 105.55万美元 | 未持股 | 2023-06-20 |
董事简历
中英对照 | 中文 | 英文- James W. Bracke
-
James W. Bracke，自2021年8月起担任董事。Bracke博士自2004年以来一直担任商业和技术咨询公司Boulder Creek Consulting，LLC的总裁。2014年4月至2018年9月，他在私营医疗设备公司EPIEN Medical Inc.担任口腔健康副总裁。Bracke博士曾于1983年至2004年担任Lifecore Biomedical，Inc.的总裁兼首席执行官，该公司是一家上市医疗设备制造商。自2009年以来，他一直担任Autoscope Technologies Corporation（原Image Sensing Systems, Inc.）的董事。Autoscope是一家上市公司，致力于通过开发和提供地上检测技术、应用和解决方案，帮助提高城市和高速公路的安全性和效率。Bracke博士是Autoscope审计委员会、提名和公司治理委员会以及薪酬委员会的成员。2011年9月至2016年6月担任图像传感系统董事会主席。Bracke博士在艾奥瓦大学医学院获得微生物学博士学位。
James W. Bracke,has been a director since August 2021. Dr. Bracke has been President of Boulder Creek Consulting, LLC, a business and technology consulting firm, since 2004. He was Vice President of Oral Health at EPIEN Medical Inc., a privately-held medical device company, from April 2014 to September 2018. Dr. Bracke was President and CEO of Lifecore Biomedical, Inc., a publicly-held medical device manufacturer, from 1983 to 2004. He has been a director of Autoscope Technologies Corporation (formerly Image Sensing Systems, Inc.) since 2009. Autoscope is a publically-held corporation dedicated to helping improve safety and efficiency for cities and highways by developing and delivering above-ground detection technology, applications, and solutions. Dr. Bracke is a member of Autoscope's Audit Committee, Nominating and Corporate Governance Committee, and Compensation Committee. He was Chairman of the Image Sensing Systems Board from September 2011 until June 2016. Dr. Bracke received a Ph.D. in microbiology from the University of Iowa College of Medicine. - James W. Bracke，自2021年8月起担任董事。Bracke博士自2004年以来一直担任商业和技术咨询公司Boulder Creek Consulting，LLC的总裁。2014年4月至2018年9月，他在私营医疗设备公司EPIEN Medical Inc.担任口腔健康副总裁。Bracke博士曾于1983年至2004年担任Lifecore Biomedical，Inc.的总裁兼首席执行官，该公司是一家上市医疗设备制造商。自2009年以来，他一直担任Autoscope Technologies Corporation（原Image Sensing Systems, Inc.）的董事。Autoscope是一家上市公司，致力于通过开发和提供地上检测技术、应用和解决方案，帮助提高城市和高速公路的安全性和效率。Bracke博士是Autoscope审计委员会、提名和公司治理委员会以及薪酬委员会的成员。2011年9月至2016年6月担任图像传感系统董事会主席。Bracke博士在艾奥瓦大学医学院获得微生物学博士学位。
- James W. Bracke,has been a director since August 2021. Dr. Bracke has been President of Boulder Creek Consulting, LLC, a business and technology consulting firm, since 2004. He was Vice President of Oral Health at EPIEN Medical Inc., a privately-held medical device company, from April 2014 to September 2018. Dr. Bracke was President and CEO of Lifecore Biomedical, Inc., a publicly-held medical device manufacturer, from 1983 to 2004. He has been a director of Autoscope Technologies Corporation (formerly Image Sensing Systems, Inc.) since 2009. Autoscope is a publically-held corporation dedicated to helping improve safety and efficiency for cities and highways by developing and delivering above-ground detection technology, applications, and solutions. Dr. Bracke is a member of Autoscope's Audit Committee, Nominating and Corporate Governance Committee, and Compensation Committee. He was Chairman of the Image Sensing Systems Board from September 2011 until June 2016. Dr. Bracke received a Ph.D. in microbiology from the University of Iowa College of Medicine.
- Terrence W. Glarner
-
Terrence W. Glarner，自1999年起担任董事，自2001年1月起担任董事会主席。1993年以来，他一直担任West Concord Ventures, Inc.（风险投资公司）的总裁。他曾担任其他几家上市公司的董事。他也是私人控股公司Bremer Financial Corp.的董事，直到2018年退休。他持有the University of St. Thomas的英语学士学位、the University of Minnesota School of Law的法学博士学位，也是一名特许金融分析师。
Terrence W. Glarner,has been a director since 1999 and Chairman of the Board since January 2001. Since 1993, Mr. Glarner has been President of West Concord Ventures, Inc., a venture capital company. He has served as a director of several other publicly traded companies in the past. He was also a director of Bremer Financial Corp., a privately held company, until retiring in 2018. Mr. Glarner has a B.A. in English from the University of St. Thomas, a J.D. from the University of Minnesota School of Law, and is a Chartered Financial Analyst. - Terrence W. Glarner，自1999年起担任董事，自2001年1月起担任董事会主席。1993年以来，他一直担任West Concord Ventures, Inc.（风险投资公司）的总裁。他曾担任其他几家上市公司的董事。他也是私人控股公司Bremer Financial Corp.的董事，直到2018年退休。他持有the University of St. Thomas的英语学士学位、the University of Minnesota School of Law的法学博士学位，也是一名特许金融分析师。
- Terrence W. Glarner,has been a director since 1999 and Chairman of the Board since January 2001. Since 1993, Mr. Glarner has been President of West Concord Ventures, Inc., a venture capital company. He has served as a director of several other publicly traded companies in the past. He was also a director of Bremer Financial Corp., a privately held company, until retiring in 2018. Mr. Glarner has a B.A. in English from the University of St. Thomas, a J.D. from the University of Minnesota School of Law, and is a Chartered Financial Analyst.
- Daniel A. Baker
-
Daniel A. Baker，从2001年起，他担任NVE的总裁和首席执行官。他有着超过35年的主席和工程经验。从1993年至加入NVE之前，他担任Printware, Inc.（现在的Printware LLC）的总裁和首席执行官，该公司生产销售告诉成像系统。从1993年至2000年6月，他担任Printware的董事，该公司是上市公司，1996年在他在位期间，开始了首次公开募股。他在明尼苏达大学（University of Minnesota）获得工程学博士学位和工商管理学硕士学位并在凯斯西储大学（Case Western Reserve University）获得工程学学士学位。
Daniel A. Baker,has been a director and NVE's President and CEO since 2001. From 1993 until joining NVE, he was President and CEO of Printware, Inc., which manufactures and markets high-speed imaging systems. Prior to being named President and CEO, he was Printware's Vice President of Sales, Marketing, and Product Development. He was a Printware director from 1993 to 2000. Printware was publicly traded beginning with its initial public stock offering in 1996 through Dr. Baker's tenure. He also served as Director of Electronic Development for Minntech Corporation (now Cantel Medical Corp., a STERIS company) and Director of Engineering for Percom Data Corporation. Dr. Baker holds Ph.D. in biomedical engineering and MBA degrees from the University of Minnesota, and a B.S. in biomedical engineering from Case Western Reserve University. - Daniel A. Baker，从2001年起，他担任NVE的总裁和首席执行官。他有着超过35年的主席和工程经验。从1993年至加入NVE之前，他担任Printware, Inc.（现在的Printware LLC）的总裁和首席执行官，该公司生产销售告诉成像系统。从1993年至2000年6月，他担任Printware的董事，该公司是上市公司，1996年在他在位期间，开始了首次公开募股。他在明尼苏达大学（University of Minnesota）获得工程学博士学位和工商管理学硕士学位并在凯斯西储大学（Case Western Reserve University）获得工程学学士学位。
- Daniel A. Baker,has been a director and NVE's President and CEO since 2001. From 1993 until joining NVE, he was President and CEO of Printware, Inc., which manufactures and markets high-speed imaging systems. Prior to being named President and CEO, he was Printware's Vice President of Sales, Marketing, and Product Development. He was a Printware director from 1993 to 2000. Printware was publicly traded beginning with its initial public stock offering in 1996 through Dr. Baker's tenure. He also served as Director of Electronic Development for Minntech Corporation (now Cantel Medical Corp., a STERIS company) and Director of Engineering for Percom Data Corporation. Dr. Baker holds Ph.D. in biomedical engineering and MBA degrees from the University of Minnesota, and a B.S. in biomedical engineering from Case Western Reserve University.
- Patricia M. Hollister
-
Patricia M. Hollister，从2004年起，她担任董事。2012年10月FSI International, Inc. FSI 被Tokyo Electron Limited收购后，她担任TEL FSI, Inc.的财政和管理副总裁。TEL FSI, Inc. 设计、生产、营销和支持微电子学制造设备。从1998年至2012年10月，她担任FSI的首席财务官。FSI在被收购前一直是上市公司。1995年，加入FSI之前，她就职于KPMG LLP，在多个审计和咨询职位上工作了超过12年，最近的是担任高级经理。她在圣克劳德州立大学（St. Cloud State University）获得会计学学士学位。
Patricia M. Hollister,has been a director since 2004. She was Director of Finance for TEL FSI, Inc. (now TEL Manufacturing and Engineering of America, Inc., or "TMEA") until retiring in 2016. TMEA designs, manufactures, markets, and supports equipment Nve Corporation ed in the fabrication of microelectronics. Ms. Hollister served as chief financial officer of FSI International Inc. ("FSI") from 1998 until it was acquired by TEL in 2012. FSI was publicly traded until it was acquired. Prior to joining FSI in 1995, Ms. Hollister was employed by KPMG LLP, where she served for more than 12 years on various audit and consulting engagements, most recently as a Senior Manager. Ms. Hollister holds a BS in Accounting from St. Cloud State University. - Patricia M. Hollister，从2004年起，她担任董事。2012年10月FSI International, Inc. FSI 被Tokyo Electron Limited收购后，她担任TEL FSI, Inc.的财政和管理副总裁。TEL FSI, Inc. 设计、生产、营销和支持微电子学制造设备。从1998年至2012年10月，她担任FSI的首席财务官。FSI在被收购前一直是上市公司。1995年，加入FSI之前，她就职于KPMG LLP，在多个审计和咨询职位上工作了超过12年，最近的是担任高级经理。她在圣克劳德州立大学（St. Cloud State University）获得会计学学士学位。
- Patricia M. Hollister,has been a director since 2004. She was Director of Finance for TEL FSI, Inc. (now TEL Manufacturing and Engineering of America, Inc., or "TMEA") until retiring in 2016. TMEA designs, manufactures, markets, and supports equipment Nve Corporation ed in the fabrication of microelectronics. Ms. Hollister served as chief financial officer of FSI International Inc. ("FSI") from 1998 until it was acquired by TEL in 2012. FSI was publicly traded until it was acquired. Prior to joining FSI in 1995, Ms. Hollister was employed by KPMG LLP, where she served for more than 12 years on various audit and consulting engagements, most recently as a Senior Manager. Ms. Hollister holds a BS in Accounting from St. Cloud State University.
- Richard W. Kramp
-
Richard W. Kramp是第一候选人。2007年1月至2012年2月，他曾是多元化的医疗器械公司Synovis Life Technologies公司的首席执行官兼董事。2012年2月，Synovis在被百特国际有限公司（Baxter International, Inc.）收购后，公开上市。2006年6月至2007年1月，他担任Synovis总裁；2004年8月至2006年5月，担任Synovis前介业务单元的总裁兼首席营运官。加入Synovis前，他在医疗器械公司Medical CV公司，先担任新产品开发副总裁，之后担任总裁兼首席营运官。1988年至2003年，他在如今美敦力公司（Medtronic, Inc.）旗下的ATS Medical公司，先担任总裁兼首席营运官，之后担任总裁、首席执行官兼董事。1981年至1988年，担任圣犹达公司（St. Jude Medical, Inc.）的销售和营销副总裁。此前，他曾在如今波士顿科学（Boston Scientific, Inc.）旗下的Cardiac Pacemakers公司担任过工程类职位。2013年5月起，他担任公开上市医疗器械公司Vascular Solutions公司的董事。他也是私人控股早期阶段医疗器械公司AUM Cardiovascular的董事；之前他也曾任职于公开上市的医疗器械公司Rochester Medical Corporation的董事会。他获得了马凯特大学（Marquette University）电气工程学士学位。
Richard W. Kramp,has been a director since 2014. Mr. Kramp was the CEO and a director of Synovis Life Technologies, Inc., a diversified medical device company, from January 2007 to February 2012. Synovis was publicly traded until it was purchased by Baxter International, Inc. in February 2012. Mr. Kramp served as President of Synovis from June 2006 to January 2007, and from August 2004 to May 2006, he served as President and Chief Operating Officer of the former interventional business unit of Synovis. Prior to joining Synovis, Mr. Kramp served as the President and Chief Operating Officer of Medical CV, Inc., a medical device company, and before that, as its Vice President of New Product Development. From 1988 to 2003, Mr. Kramp served as President and Chief Operating Officer, and then President and CEO, as well as a director of ATS Medical, Inc. (now part of Medtronic, Inc.). Mr. Kramp served as National Sales Manager, then as Director of Sales and Marketing, and then as Vice President of Sales and Marketing for St. Jude Medical, Inc. (now part of Abbott Laboratories) from 1978 to 1988. Prior to that, Mr. Kramp held engineering positions with Cardiac Pacemakers, Inc. (now part of Boston Scientific, Inc.). He was also a director of Vascular Solutions, Inc., a publicly traded medical device company, from May 2013 until its acquisition by Teleflex Corporation in February 2017. He previously served on the board of Rochester Medical Corporation when it was a publicly held medical device company. Mr. Kramp holds a Bachelor's Degree in Electrical Engineering from Marquette University. - Richard W. Kramp是第一候选人。2007年1月至2012年2月，他曾是多元化的医疗器械公司Synovis Life Technologies公司的首席执行官兼董事。2012年2月，Synovis在被百特国际有限公司（Baxter International, Inc.）收购后，公开上市。2006年6月至2007年1月，他担任Synovis总裁；2004年8月至2006年5月，担任Synovis前介业务单元的总裁兼首席营运官。加入Synovis前，他在医疗器械公司Medical CV公司，先担任新产品开发副总裁，之后担任总裁兼首席营运官。1988年至2003年，他在如今美敦力公司（Medtronic, Inc.）旗下的ATS Medical公司，先担任总裁兼首席营运官，之后担任总裁、首席执行官兼董事。1981年至1988年，担任圣犹达公司（St. Jude Medical, Inc.）的销售和营销副总裁。此前，他曾在如今波士顿科学（Boston Scientific, Inc.）旗下的Cardiac Pacemakers公司担任过工程类职位。2013年5月起，他担任公开上市医疗器械公司Vascular Solutions公司的董事。他也是私人控股早期阶段医疗器械公司AUM Cardiovascular的董事；之前他也曾任职于公开上市的医疗器械公司Rochester Medical Corporation的董事会。他获得了马凯特大学（Marquette University）电气工程学士学位。
- Richard W. Kramp,has been a director since 2014. Mr. Kramp was the CEO and a director of Synovis Life Technologies, Inc., a diversified medical device company, from January 2007 to February 2012. Synovis was publicly traded until it was purchased by Baxter International, Inc. in February 2012. Mr. Kramp served as President of Synovis from June 2006 to January 2007, and from August 2004 to May 2006, he served as President and Chief Operating Officer of the former interventional business unit of Synovis. Prior to joining Synovis, Mr. Kramp served as the President and Chief Operating Officer of Medical CV, Inc., a medical device company, and before that, as its Vice President of New Product Development. From 1988 to 2003, Mr. Kramp served as President and Chief Operating Officer, and then President and CEO, as well as a director of ATS Medical, Inc. (now part of Medtronic, Inc.). Mr. Kramp served as National Sales Manager, then as Director of Sales and Marketing, and then as Vice President of Sales and Marketing for St. Jude Medical, Inc. (now part of Abbott Laboratories) from 1978 to 1988. Prior to that, Mr. Kramp held engineering positions with Cardiac Pacemakers, Inc. (now part of Boston Scientific, Inc.). He was also a director of Vascular Solutions, Inc., a publicly traded medical device company, from May 2013 until its acquisition by Teleflex Corporation in February 2017. He previously served on the board of Rochester Medical Corporation when it was a publicly held medical device company. Mr. Kramp holds a Bachelor's Degree in Electrical Engineering from Marquette University.
高管简历
中英对照 | 中文 | 英文- Peter G. Eames
PeterG.Eames，于2017财年从高级技术总监晋升为高级技术Vice President。他在明尼苏达大学（University of Minnesota）完成实验凝聚态物理博士学位后，自2003年加入公司以来，一直以各种身份担任NVE员工。
Peter G. Eames,was promoted to Vice President of Advanced Technology from Director of Advanced Technology in 2016. He has been an NVE employee in various capacities since joining the Company in 2003 after completing his Ph.D. in experimental condensed matter physics from the University of Minnesota.- PeterG.Eames，于2017财年从高级技术总监晋升为高级技术Vice President。他在明尼苏达大学（University of Minnesota）完成实验凝聚态物理博士学位后，自2003年加入公司以来，一直以各种身份担任NVE员工。
- Peter G. Eames,was promoted to Vice President of Advanced Technology from Director of Advanced Technology in 2016. He has been an NVE employee in various capacities since joining the Company in 2003 after completing his Ph.D. in experimental condensed matter physics from the University of Minnesota.
- Daniel Nelson
丹尼尔·尼尔森于2023年5月8日被任命为会计经理兼首席财务官。他于2022年9月加入NVE，担任高级会计师。从2021年8月到加入NVE，他在明尼苏达州普利茅斯的RMH Tax & Business Advisors工作，从2015年5月到2021年7月，他在明尼苏达州普利茅斯的Intelligere担任高级会计师。他在利比里亚大学获得会计学学士和硕士学位，并在利比里亚的贝克蒂利开始了他的职业生涯。
Daniel Nelson,was appointed Accounting Manager and Principal Financial Officer on May 8, 2023. He joined NVE in September 2022 as Senior Accountant. From August 2021 until joining NVE, he worked at RMH Tax & Business Advisors in Plymouth, Minn., and from May 2015 to July 2021 he was a senior accountant at Intelligere in Plymouth, Minn. He earned bachelor's and master's degrees in accounting from the University of Liberia and started his career at Baker Tilly in Liberia.- 丹尼尔·尼尔森于2023年5月8日被任命为会计经理兼首席财务官。他于2022年9月加入NVE，担任高级会计师。从2021年8月到加入NVE，他在明尼苏达州普利茅斯的RMH Tax & Business Advisors工作，从2015年5月到2021年7月，他在明尼苏达州普利茅斯的Intelligere担任高级会计师。他在利比里亚大学获得会计学学士和硕士学位，并在利比里亚的贝克蒂利开始了他的职业生涯。
- Daniel Nelson,was appointed Accounting Manager and Principal Financial Officer on May 8, 2023. He joined NVE in September 2022 as Senior Accountant. From August 2021 until joining NVE, he worked at RMH Tax & Business Advisors in Plymouth, Minn., and from May 2015 to July 2021 he was a senior accountant at Intelligere in Plymouth, Minn. He earned bachelor's and master's degrees in accounting from the University of Liberia and started his career at Baker Tilly in Liberia.
- Daniel A. Baker
Daniel A. Baker，从2001年起，他担任NVE的总裁和首席执行官。他有着超过35年的主席和工程经验。从1993年至加入NVE之前，他担任Printware, Inc.（现在的Printware LLC）的总裁和首席执行官，该公司生产销售告诉成像系统。从1993年至2000年6月，他担任Printware的董事，该公司是上市公司，1996年在他在位期间，开始了首次公开募股。他在明尼苏达大学（University of Minnesota）获得工程学博士学位和工商管理学硕士学位并在凯斯西储大学（Case Western Reserve University）获得工程学学士学位。
Daniel A. Baker,has been a director and NVE's President and CEO since 2001. From 1993 until joining NVE, he was President and CEO of Printware, Inc., which manufactures and markets high-speed imaging systems. Prior to being named President and CEO, he was Printware's Vice President of Sales, Marketing, and Product Development. He was a Printware director from 1993 to 2000. Printware was publicly traded beginning with its initial public stock offering in 1996 through Dr. Baker's tenure. He also served as Director of Electronic Development for Minntech Corporation (now Cantel Medical Corp., a STERIS company) and Director of Engineering for Percom Data Corporation. Dr. Baker holds Ph.D. in biomedical engineering and MBA degrees from the University of Minnesota, and a B.S. in biomedical engineering from Case Western Reserve University.- Daniel A. Baker，从2001年起，他担任NVE的总裁和首席执行官。他有着超过35年的主席和工程经验。从1993年至加入NVE之前，他担任Printware, Inc.（现在的Printware LLC）的总裁和首席执行官，该公司生产销售告诉成像系统。从1993年至2000年6月，他担任Printware的董事，该公司是上市公司，1996年在他在位期间，开始了首次公开募股。他在明尼苏达大学（University of Minnesota）获得工程学博士学位和工商管理学硕士学位并在凯斯西储大学（Case Western Reserve University）获得工程学学士学位。
- Daniel A. Baker,has been a director and NVE's President and CEO since 2001. From 1993 until joining NVE, he was President and CEO of Printware, Inc., which manufactures and markets high-speed imaging systems. Prior to being named President and CEO, he was Printware's Vice President of Sales, Marketing, and Product Development. He was a Printware director from 1993 to 2000. Printware was publicly traded beginning with its initial public stock offering in 1996 through Dr. Baker's tenure. He also served as Director of Electronic Development for Minntech Corporation (now Cantel Medical Corp., a STERIS company) and Director of Engineering for Percom Data Corporation. Dr. Baker holds Ph.D. in biomedical engineering and MBA degrees from the University of Minnesota, and a B.S. in biomedical engineering from Case Western Reserve University.